[RGLS] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
18-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 16.65%
YoY- 40.73%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 18 18 6,778 18 18 18 18 0.00%
PBT -5,423 -5,015 -3,260 -8,502 -10,273 -13,847 -16,024 -51.40%
Tax 87 1 56 61 201 118 1 1858.09%
NP -5,423 -5,016 -3,260 -8,563 -10,273 -13,847 -16,025 -51.40%
Tax Rate - - - - - - - -
Total Cost 5,441 5,034 10,038 8,581 10,291 13,865 16,043 -51.33%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -30,127.78 -27,866.67 -48.10 -47,572.22 -57,072.22 -76,927.78 -89,027.78 -51.40%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -2.60 -3.00 -3.14 -9.75 -11.80 -15.93 -18.49 -72.92%
EPS Diluted -2.60 -3.00 -3.14 -9.75 -11.80 -15.93 -18.49 -72.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.